Predictive value of vascular endothelial growth factor A (VEGF-A) for bevacizumab-based treatments across advanced cancers: a meta-analysis based on eight phase III randomized control trials involving 4,523 patients

    Annals of Oncology, 2016.

    Cited by: 0|Bibtex|Views0|

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments